DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Keravis T, Lugnier C.
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.
Br J Pharmacol 2012;
165 (05) 1288-1305
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.